Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited

BMC Infect Dis. 2004 Jun 30:4:21. doi: 10.1186/1471-2334-4-21.

Abstract

Background: Invasive infection with Streptococcus pneumoniae (pneumococci) causes significant morbidity and mortality. Case series and experimental data have shown that the capsular serotype is involved in the pathogenesis and a determinant of disease outcome.

Methods: Retrospective review of 464 cases of invasive disease among adults diagnosed between 1990 and 2001. Multivariate Cox proportional hazard analysis.

Results: After adjustment for other markers of disease severity, we found that infection with serotype 3 was associated with an increased relative risk (RR) of death of 2.54 (95% confidence interval (CI): 1.22-5.27), whereas infection with serotype 1 was associated with a decreased risk of death (RR 0.23 (95% CI, 0.06-0.97)). Additionally, older age, relative leucopenia and relative hypothermia were independent predictors of mortality.

Conclusion: Our study shows that capsular serotypes independently influenced the outcome from invasive pneumococcal disease. The limitations of the current polysaccharide pneumococcal vaccine warrant the development of alternative vaccines. We suggest that the virulence of pneumococcal serotypes should be considered in the design of novel vaccines.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Bacteremia / microbiology
  • Bacteremia / mortality
  • Bacterial Capsules / classification*
  • Drug Resistance, Bacterial
  • Female
  • Hospital Mortality
  • Humans
  • Male
  • Meningitis, Pneumococcal / microbiology
  • Meningitis, Pneumococcal / mortality
  • Middle Aged
  • Otitis Media / microbiology
  • Otitis Media / mortality
  • Pneumococcal Infections / microbiology*
  • Pneumococcal Infections / mortality*
  • Pneumonia, Pneumococcal / microbiology
  • Pneumonia, Pneumococcal / mortality
  • Retrospective Studies
  • Serotyping
  • Streptococcus pneumoniae / classification*
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / pathogenicity
  • Virulence